Federal grand jury investigating former FDA head Crawford over financial impropriety allegations.
According to financial disclosure forms, Crawford and his wife held shares in several companies whose business is regulated by the FDA as late as 2004. Crawford left the FDA in September 2005 just two months after being confirmed by the Senate. He held the post as acting commissioner for a little more than a year prior to his confirmation.
Crawford's lawyer Barbara Van Gelder told a federal magistrate in a court hearing conducted by phone that she would tell him to invoke his Fifth Amendment rights against compelled self-incrimination if asked to respond to questions about his actions as FDA commissioner, the New York Times reported.
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||United States. Food and Drug Administration investigates against Lester Crawford|
|Article Type:||Brief article|
|Date:||May 12, 2006|
|Previous Article:||Embryonic stem cell research guidelines issued by NRC, IOM.|
|Next Article:||UPMC School of Nursing to study factors predicting health outcomes of liver transplant recipients.|
|Crawford tapped to head FDA.|
|Nomination of Crawford to head FDA draws mostly positive reaction.|